Prognostic significance of CD30 expression in diffuse large B-cell lymphoma: A systematic review with meta-analysis

Carla Isabelly Rodrigues-Fernandes, Lucas Guimarães Abreu, Raghu Radhakrishnan, Danyel Elias da Cruz Perez, Gleyson Kleber Amaral-Silva, Rogério de Oliveira Gondak, Siavash Rahimi, Peter A. Brennan, Felipe Paiva Fonseca, Pablo Agustin Vargas

Research output: Contribution to journalArticlepeer-review

Abstract

Background: CD30 is variably expressed in diffuse large B-cell lymphoma (DLBCL), but its prognostic potential for the affected patients remains debatable and unclear. Therefore, we aimed to determine the frequency of CD30 expression in DLBCL and its potential for prognostic determination. Methods: An electronic systematic review was performed using multiple databases, followed by a quantitative meta-analysis to assess the frequency of CD30 expression with positivity cut-off values of >0% and >20%, and to determine its association with clinicopathological features and patients’ survival. Results: Using a cut-off value >0%, we observed that 3.5%–59.1% of the cases were considered positive for CD30. There was a significant association of the protein expression with a lower number of extra-nodal sites affected by the neoplasm, with Ann Arbor advanced stage, the absence of B-symptoms, the lack of MYC and BCL2 translocations, and a lower ECOG performance. Using a cut-off value >20%, we observed that 2.5%–36.7% of the cases were considered positive for CD30, being significantly associated with a lower number of extra-nodal sites affected by the neoplasm, Ann Arbor stages III/IV, non-GCB tumours, the lack of MYC and BCL2 translocations, and a lower ECOG value. CD30 expression was significantly associated with a better survival rate, regardless of what cut-off parameter was used. Conclusion: Despite variations in the cut-off values used to determine CD30 positivity in DLBCL, the expression of this protein seems to be associated with a higher survival rate and better prognosis.

Original languageEnglish
Pages (from-to)587-593
Number of pages7
JournalJournal of Oral Pathology and Medicine
Volume50
Issue number6
DOIs
Publication statusPublished - 07-2021

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Oral Surgery
  • Otorhinolaryngology
  • Cancer Research
  • Periodontics

Fingerprint

Dive into the research topics of 'Prognostic significance of CD30 expression in diffuse large B-cell lymphoma: A systematic review with meta-analysis'. Together they form a unique fingerprint.

Cite this